MX2022006776A - Composiciones farmaceuticas oftalmicas. - Google Patents
Composiciones farmaceuticas oftalmicas.Info
- Publication number
- MX2022006776A MX2022006776A MX2022006776A MX2022006776A MX2022006776A MX 2022006776 A MX2022006776 A MX 2022006776A MX 2022006776 A MX2022006776 A MX 2022006776A MX 2022006776 A MX2022006776 A MX 2022006776A MX 2022006776 A MX2022006776 A MX 2022006776A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical compositions
- ophthalmic pharmaceutical
- ophthalmic
- compound
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
La presente invención proporciona composiciones farmacéuticas oftálmicas del compuesto de la Fórmula I: (ver Fórmula) (I).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962944074P | 2019-12-05 | 2019-12-05 | |
US202063077196P | 2020-09-11 | 2020-09-11 | |
PCT/US2020/063218 WO2021113580A1 (en) | 2019-12-05 | 2020-12-04 | Ophthalmic pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022006776A true MX2022006776A (es) | 2022-09-19 |
Family
ID=74104179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022006776A MX2022006776A (es) | 2019-12-05 | 2020-12-04 | Composiciones farmaceuticas oftalmicas. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20230026577A1 (es) |
EP (1) | EP4069195A1 (es) |
JP (1) | JP2023505255A (es) |
KR (1) | KR20220128619A (es) |
CN (1) | CN115397392A (es) |
AU (1) | AU2020398224A1 (es) |
BR (1) | BR112022010871A2 (es) |
CA (1) | CA3160484A1 (es) |
CL (1) | CL2022001463A1 (es) |
CO (1) | CO2022009260A2 (es) |
IL (1) | IL293541A (es) |
MX (1) | MX2022006776A (es) |
TW (1) | TW202128178A (es) |
WO (1) | WO2021113580A1 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108848668B (zh) | 2015-12-24 | 2022-04-26 | 加利福尼亚大学董事会 | Cftr调节剂及其使用方法 |
US11839616B2 (en) * | 2017-08-24 | 2023-12-12 | The Regents Of The University Of California | Ocular pharmaceutical compositions |
-
2020
- 2020-12-04 BR BR112022010871A patent/BR112022010871A2/pt unknown
- 2020-12-04 TW TW109142969A patent/TW202128178A/zh unknown
- 2020-12-04 WO PCT/US2020/063218 patent/WO2021113580A1/en unknown
- 2020-12-04 KR KR1020227022823A patent/KR20220128619A/ko active Search and Examination
- 2020-12-04 AU AU2020398224A patent/AU2020398224A1/en active Pending
- 2020-12-04 US US17/782,197 patent/US20230026577A1/en active Pending
- 2020-12-04 EP EP20830416.2A patent/EP4069195A1/en active Pending
- 2020-12-04 IL IL293541A patent/IL293541A/en unknown
- 2020-12-04 MX MX2022006776A patent/MX2022006776A/es unknown
- 2020-12-04 CN CN202080094414.9A patent/CN115397392A/zh active Pending
- 2020-12-04 CA CA3160484A patent/CA3160484A1/en active Pending
- 2020-12-04 JP JP2022533510A patent/JP2023505255A/ja active Pending
-
2022
- 2022-06-02 CL CL2022001463A patent/CL2022001463A1/es unknown
- 2022-07-01 CO CONC2022/0009260A patent/CO2022009260A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2023505255A (ja) | 2023-02-08 |
AU2020398224A1 (en) | 2022-06-30 |
WO2021113580A1 (en) | 2021-06-10 |
BR112022010871A2 (pt) | 2022-08-23 |
CA3160484A1 (en) | 2021-06-10 |
CO2022009260A2 (es) | 2022-09-20 |
CL2022001463A1 (es) | 2023-02-10 |
IL293541A (en) | 2022-08-01 |
TW202128178A (zh) | 2021-08-01 |
CN115397392A (zh) | 2022-11-25 |
KR20220128619A (ko) | 2022-09-21 |
US20230026577A1 (en) | 2023-01-26 |
EP4069195A1 (en) | 2022-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12021500014A1 (en) | Fused ring compounds | |
PH12021551065A1 (en) | Fused ring compounds | |
MX2021014441A (es) | Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos. | |
MX2021002978A (es) | Lactamas biciclicas y metodos de uso de las mismas. | |
MX2021014443A (es) | Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos. | |
PH12018501099A1 (en) | Novel biphenyl compound or salt thereof | |
MX2023008031A (es) | Inhibidores de la cinasa 2 de control general no desrepresible (gcn2) y usos de los mismos. | |
MX2021005714A (es) | Nuevos compuestos heterociclicos. | |
MX2020007799A (es) | Inhibidores de cinasa no derrepresible de control de aminoacido general 2 (gcn2) y sus usos. | |
PH12020500655A1 (en) | Compounds | |
GEP20217281B (en) | 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer | |
MX2020009234A (es) | Compuestos de heteroarilo como inhibidores de cinasas asociadas con receptores de interleucina-1 (irak) tipo ii y usos de los mismos. | |
MX2019014104A (es) | Compuesto novedoso de bifenilo o sal del mismo. | |
CR20200116A (es) | Compuestos de bisamida que activan el sarcómero y sus usos | |
MX2022006783A (es) | Nuevos derivados de metilquinazolinona. | |
MX2020013630A (es) | Analogos de rapamicina y usos de los mismos. | |
MX2020014097A (es) | Lipidos novedosos. | |
WO2018039077A8 (en) | Therapeutic compounds | |
MX2020012281A (es) | Composiciones que comprenden compuestos de bisfluoroalquil-1,4-ben zodiacepinona y metodos de uso de las mismas. | |
MX2021004386A (es) | Compuestos novedosos. | |
MX2021001904A (es) | Formas solidas de benzoxaborol sustituido y composiciones de las mismas. | |
MX2019008375A (es) | Tiobenzoimidazol como fungicidas. | |
MX2021003888A (es) | Nuevos compuestos utiles para el tratamiento de enfermedades cardiovasculares. | |
MY188420A (en) | Crystalline forms of (s)-afoxolaner | |
MX2022006776A (es) | Composiciones farmaceuticas oftalmicas. |